Amdocs (DOX) Reports Q3 Earnings: What Key Metrics Have to Say

Amdocs (DOX) reported $1.14 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 8.5%. EPS of $1.72 for the same period compares to $1.62 a year ago.The reported revenue represents a surprise of +1.37% over the Zacks Consensus Estimate of $1.13 billion. With the consensus EPS estimate being $1.71, the EPS surprise was +0.58%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Amdocs performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Geographic Revenue- North America: $745.4 million versus $740.52 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -10.1% change.Geographic Revenue- Rest of the world: $209.6 million versus the two-analyst average estimate of $225.87 million. The reported number represents a year-over-year change of -14.6%.Geographic Revenue- Europe: $189.4 million versus the two-analyst average estimate of $162.04 million. The reported number represents a year-over-year change of +7.7%.Revenue- Managed Services Revenue: $771.5 million versus the two-analyst average estimate of $724.77 million. The reported number represents a year-over-year change of +4.1%.View all Key Company Metrics for Amdocs here>>>Shares of Amdocs have returned -8.5% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Amdocs Limited (DOX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks